Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical outcomes assessment in multiple sclerosis

R Rudick1, J Antel, C Confavreux

  • 1Mellen Center, Cleveland Clinic Foundation, OH, USA.

Annals of Neurology
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of dopamine on T-lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients.

Critical care medicine·1992
Same author

Lung function testing: selection of reference values and interpretative strategies.

The American review of respiratory disease·1992
Same author

Defense behavior and coping in an autistic savant: the story of Temple Grandin, PhD.

Psychiatry·1992
Same author

Comparative quantitative evaluation of pleural fibrosis and its effects on pulmonary function in two large asbestos-exposed occupational groups--insulators and sheet metal workers.

Environmental research·1992
Same author

Identification of a repetitive element in the snail Biomphalaria glabrata: relationship to the reverse transcriptase-encoding sequence in LINE-1 transposons.

Gene·1992
Same author

On creativity.

Arthritis and rheumatism·1992

This task force is developing recommendations for optimal clinical assessment tools in multiple sclerosis (MS) clinical trials. Key issues discussed include measurement dimensions, tool attributes, and assessment types for better MS research outcomes.

Area of Science:

  • Neurology
  • Clinical Trials
  • Biostatistics

Background:

  • Multiple Sclerosis (MS) clinical trials require standardized and optimal assessment tools.
  • An international task force was convened by the US National Multiple Sclerosis Society to address this need.
  • Initial deliberations focused on identifying critical issues in developing effective assessment measures.

Purpose of the Study:

  • To outline the key considerations for developing optimal clinical assessment tools for MS clinical trials.
  • To identify and discuss critical issues in the design and implementation of multidimensional outcome measures.
  • To establish a foundation for future recommendations on MS assessment strategies.

Main Methods:

  • The study involved initial deliberations of an international task force.

Related Experiment Videos

  • Key issues were identified through expert discussion and consensus-building.
  • The process included reviewing existing practices and considering future directions for MS outcome measures.

    • Main Results:

    • Identified key issues include defining the purpose of assessment tools.
    • Discussed clinical dimensions, desirable attributes, and complexities of multidimensional outcome measures.
    • Compared the merits of categorical ratings versus quantitative functional assessments in MS trials.

    Conclusions:

    • The task force has identified crucial areas for developing improved clinical assessment tools for MS.
    • An action plan for data analysis and further recommendations is outlined.
    • These deliberations are foundational for enhancing the rigor and validity of future MS clinical trials.